Portola Pharma (PTLA) Tops Q1 EPS by 14c

Portola Pharma (NASDAQ: PTLA) reported Q1 EPS of ($0.95), $0.14 better than the analyst estimate of ($1.09). Revenue for the quarter came in at $2.36 million versus the consensus estimate of $2.6 million.

For earnings history and earnings-related data on Portola Pharma (PTLA) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Aon names interim CFO as Edmund Reese exits the firm
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low